Adverum Biotechnologies Inc
NASDAQ: advm
$1.39
USD
-$0.03
-2.11%
Prev Close
$1.42
Today's Open
$1.42
Volume
0.00
Market Cap
136.43M
Day Range
52W Range
Overview
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops candidate gene therapy products to treat eye and rare diseases. The company is headquartered in Redwood City, California.
Read moreCurrent Price
15 min delay
Catalysts
There are currently no catalysts for ADVM. If there's something you'd like to see, feel free to reach out to us on discord.
Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)
Insufficient Data
Ratios
Valuation Ratios
EPS (TTM)
-1.52
P/E Ratio
0
Price to Sales
18.45
Price to Book
0.423
Profit Ratios
Profit Margin
0.00%
EBITDA Margin
-796.59%
Net Profit Margin
-977.45%
ROA
-18.40%
Total Revenue
$7.50M
Net Profit
-$73.31M
EV to EBITDA
0.446
EV to Revenue
3.7006K